(Alliance News) - Stock prices in London were lower at midday Friday, with losses accelerating after a muted open as conflicting signals over Iran weighed on sentiment. Read More
(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 edging higher despite continued uncertainty regarding Iran peace talks and muted sentiment across European markets. Read More
(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More
(Alliance News) - Daiichi Sankyo Co Ltd announced on Monday that Japan's Pharmaceuticals and Medical Devices Agency has approved an update to the prescribing information for its Enhertu treatment, expanding its use to second-line treatment of HER2-positive unresectable advanced or recurrent gastric cancer in Japan. Read More
(Alliance News) - Stock prices in London opened lower on Wednesday, as renewed tensions in the Middle East stemming from the Israel-US war against Iran kept investors in a cautious mood. Read More
(Alliance News) - AstraZeneca secures US priority review for Enhertu, GSK agrees linerixibat deal with Alfasigma, while AdvancedAdvT rules out M&C Saatchi bid. Read More
(Alliance News) - AstraZeneca PLC and Daiichi Sanyko Co Ltd on Monday reported that their co-developed breast cancer treatment Enhertu had secure priority review status in the US. Read More
(Alliance News) - European stocks were mixed in early dealings on Thursday, with markets awaiting a fresh set of catalysts after Nvidia beat on earnings overnight. Read More
(Alliance News) - The FTSE 100 reached fresh heights on Wednesday, with well-received results from HSBC, and gains in mining stocks, paving the way for another record-breaking day. Read More
(Alliance News) - Avacta Group PLC on Tuesday saw its shares rise, as it said new data demonstrates a favourable delivery profile and advantages of its preCision platform when compared to a marketed antibody drug conjugate. Read More
(Alliance News) - Stock prices in Europe moved lower in early dealings on Monday, with enthusiasm at the start of the week tempered by tariff uncertainty, as US President Donald Trump hit out at a Supreme Court ruling and announced new trade curbs. Read More